Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Influence of peer networks on physician adoption of new drugs.

Donohue JM, Guclu H, Gellad WF, Chang CH, Huskamp HA, Choudhry NK, Zhang R, Lo-Ciganic WH, Junker SP, Anderson T, Richards-Shubik S.

PLoS One. 2018 Oct 1;13(10):e0204826. doi: 10.1371/journal.pone.0204826. eCollection 2018.

2.

Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States.

Lo-Ciganic WH, Donohue JM, Kim JY, Krans EE, Jones BL, Kelley D, James AE, Jarlenski MP.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):80-89. doi: 10.1002/pds.4647. Epub 2018 Sep 7.

PMID:
30192041
3.

Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.

Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Cole E, Lobo C, Frazier W, Zheng P, Chang CH, Kelley D, Donohue JM.

J Manag Care Spec Pharm. 2018 Sep;24(9):875-885. doi: 10.18553/jmcp.2018.24.9.875.

4.

Patterns and predictors of physician adoption of new cardiovascular drugs.

Anderson TS, Lo-Ciganic WH, Gellad WF, Zhang R, Huskamp HA, Choudhry NK, Chang CH, Richards-Shubik S, Guclu H, Jones B, Donohue JM.

Healthc (Amst). 2018 Mar;6(1):33-40. doi: 10.1016/j.hjdsi.2017.09.004. Epub 2017 Oct 21.

PMID:
29066168
5.

Misoprostol in Addition to a Double-Balloon Catheter for Induction: A Double-Blind Randomized Controlled Trial.

Hill MG, Gonzalez MG, Lo-Ciganic WH, Reed KL.

Am J Perinatol. 2018 Feb;35(3):225-232. doi: 10.1055/s-0037-1606606. Epub 2017 Sep 14.

PMID:
28910848
6.

Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid.

Frazier W, Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Chang CH, Donohue JM.

JAMA. 2017 Aug 22;318(8):750-752. doi: 10.1001/jama.2017.7818. No abstract available.

7.

Medicaid prior authorization and opioid medication abuse and overdose.

Cochran G, Gordon AJ, Gellad WF, Chang CH, Lo-Ciganic WH, Lobo C, Cole E, Frazier W, Zheng P, Kelley D, Donohue JM.

Am J Manag Care. 2017 May 1;23(5):e164-e171.

8.

Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.

Almutairi AR, Zhou L, Gellad WF, Lee JK, Slack MK, Martin JR, Lo-Ciganic WH.

Clin Ther. 2017 Jul;39(7):1456-1478.e36. doi: 10.1016/j.clinthera.2017.05.358. Epub 2017 Jun 28. Review.

PMID:
28668628
9.

Analgesic use and risk of recurrent falls in participants with or at risk of knee osteoarthritis: data from the Osteoarthritis Initiative.

Lo-Ciganic WH, Floden L, Lee JK, Ashbeck EL, Zhou L, Chinthammit C, Purdy AW, Kwoh CK.

Osteoarthritis Cartilage. 2017 Sep;25(9):1390-1398. doi: 10.1016/j.joca.2017.03.017. Epub 2017 Apr 4.

10.

An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.

Cochran G, Gordon AJ, Lo-Ciganic WH, Gellad WF, Frazier W, Lobo C, Chang CH, Zheng P, Donohue JM.

Med Care. 2017 Mar;55(3):291-298. doi: 10.1097/MLR.0000000000000676.

11.

Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program.

Lo-Ciganic WH, Donohue JM, Jones BL, Perera S, Thorpe JM, Thorpe CT, Marcum ZA, Gellad WF.

J Gen Intern Med. 2016 Sep;31(9):1052-60. doi: 10.1007/s11606-016-3747-6. Epub 2016 May 26.

12.

Treatment Quality for Buprenorphine Care: The Pot at the End of the Rainbow.

Gordon A, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Donohue JM.

J Addict Med. 2016 May-Jun;10(3):210-1. doi: 10.1097/ADM.0000000000000210. No abstract available.

PMID:
27223837
13.

Who Were the Early Adopters of Dabigatran?: An Application of Group-based Trajectory Models.

Lo-Ciganic WH, Gellad WF, Huskamp HA, Choudhry NK, Chang CC, Zhang R, Jones BL, Guclu H, Richards-Shubik S, Donohue JM.

Med Care. 2016 Jul;54(7):725-32. doi: 10.1097/MLR.0000000000000549.

14.

Partnership Building and Implementation of an Integrated Healthy-Aging Program.

Zgibor JC, Schlenk EA, Vater L, Kola S, Vander Bilt J, Woody S, Jacob ME, Lo-Ciganic WH, Brenckle A, Brandenstein J, Kwoh CK, Boudreau R, Albert S, Conroy M, Rodgers E, Newman AB.

Prog Community Health Partnersh. 2016 Spring;10(1):123-32. doi: 10.1353/cpr.2016.0001.

15.

The preventive services use self-efficacy (PRESS) scale in older women: development and psychometric properties.

Jacob ME, Lo-Ciganic WH, Simkin-Silverman LR, Albert SM, Newman AB, Terhorst L, Bilt JV, Zgibor JC, Schlenk EA.

BMC Health Serv Res. 2016 Feb 20;16:71. doi: 10.1186/s12913-016-1321-x.

16.

Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization.

Lo-Ciganic WH, Gellad WF, Gordon AJ, Cochran G, Zemaitis MA, Cathers T, Kelley D, Donohue JM.

Addiction. 2016 May;111(5):892-902. doi: 10.1111/add.13270. Epub 2016 Jan 30.

PMID:
26662858
17.

Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program.

Gordon AJ, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Kelley D, Donohue JM.

J Addict Med. 2015 Nov-Dec;9(6):470-7. doi: 10.1097/ADM.0000000000000164.

PMID:
26517324
18.

Pilot Enhancement of the Arthritis Foundation Exercise Program with a Healthy Aging Program.

Schlenk EA, Bilt JV, Lo-Ciganic WH, Jacob ME, Woody SE, Conroy MB, Kwoh CK, Albert SM, Boudreau R, Newman AB, Zgibor JC.

Res Gerontol Nurs. 2016 May 1;9(3):123-32. doi: 10.3928/19404921-20151019-04. Epub 2015 Oct 26.

19.

Using machine learning to examine medication adherence thresholds and risk of hospitalization.

Lo-Ciganic WH, Donohue JM, Thorpe JM, Perera S, Thorpe CT, Marcum ZA, Gellad WF.

Med Care. 2015 Aug;53(8):720-8. doi: 10.1097/MLR.0000000000000394.

20.

Use of common analgesics is not associated with ovarian cancer survival.

Minlikeeva AN, Freudenheim JL, Lo-Ciganic WH, Eng KH, Friel G, Diergaarde B, Modugno F, Cannioto R, Gower E, Szender JB, Grzankowski K, Odunsi K, Ness RB, Moysich KB.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1291-4. doi: 10.1158/1055-9965.EPI-15-0508. Epub 2015 Jun 10.

21.

Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review.

Cochran G, Woo B, Lo-Ciganic WH, Gordon AJ, Donohue JM, Gellad WF.

Subst Abus. 2015;36(2):192-202. doi: 10.1080/08897077.2014.993491. Epub 2015 Feb 11. Review.

22.

Statin use and decline in gait speed in community-dwelling older adults.

Lo-Ciganic WH, Perera S, Gray SL, Boudreau RM, Zgibor JC, Strotmeyer ES, Donohue JM, Bunker CH, Newman AB, Simonsick EM, Bauer DC, Satterfield S, Caserotti P, Harris T, Shorr RI, Hanlon JT; Health, Aging and Body Composition Study.

J Am Geriatr Soc. 2015 Jan;63(1):124-9. doi: 10.1111/jgs.13134. Epub 2014 Dec 23.

23.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ; Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kjær SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson S, King MG, Chandran U, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike MC, Berchuck A, Schildkraut JM, Wentzensen N; Ovarian Cancer Association Consortium.

J Natl Cancer Inst. 2014 Feb;106(2):djt431. doi: 10.1093/jnci/djt431.

24.

Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults.

Lo-Ciganic WH, Boudreau RM, Gray SL, Zgibor JC, Donohue JM, Perera S, Newman AB, Simonsick EM, Bauer DC, Satterfield S, Hanlon JT.

Ann Pharmacother. 2013 Jul-Aug;47(7-8):984-92. doi: 10.1345/aph.1S050. Epub 2013 Jun 18.

25.

Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.

Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, Berchuck A, Pearce CL, Pike M, Ness RB, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Rossing MA, Schildkraut J, Risch H, Goodman MT; Ovarian Cancer Association Consortium.

Cancer Prev Res (Phila). 2013 Aug;6(8):811-21. doi: 10.1158/1940-6207.CAPR-13-0037. Epub 2013 Jun 12.

26.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer.

Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB.

Epidemiology. 2012 Mar;23(2):311-9. doi: 10.1097/EDE.0b013e3182456ad3.

27.

Identifying type 1 and type 2 diabetic cases using administrative data: a tree-structured model.

Lo-Ciganic W, Zgibor JC, Ruppert K, Arena VC, Stone RA.

J Diabetes Sci Technol. 2011 May 1;5(3):486-93.

Supplemental Content

Loading ...
Support Center